290 related articles for article (PubMed ID: 19789062)
21. The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes.
Mikhailidis DP; Press M
Expert Opin Pharmacother; 2007 Dec; 8(17):3009-20. PubMed ID: 18001259
[TBL] [Abstract][Full Text] [Related]
22. Adipokines at the crossroad between obesity and cardiovascular disease.
Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
[TBL] [Abstract][Full Text] [Related]
23. Adipotoxicity and the insulin resistance syndrome.
Anderwald C; Roden M
Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
[TBL] [Abstract][Full Text] [Related]
24. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
Fain JN
Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
[TBL] [Abstract][Full Text] [Related]
25. [Obesity--insulin resistance--type 2 diabetes mellitus].
Małecki MT
Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S561-6. PubMed ID: 20527377
[TBL] [Abstract][Full Text] [Related]
26. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
27. Adipocytokines in relation to cardiovascular disease.
Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
[TBL] [Abstract][Full Text] [Related]
28. [Obesity and inflammation].
Recasens M; Ricart W; Fernández-Real JM
Rev Med Univ Navarra; 2004; 48(2):49-54. PubMed ID: 15382613
[TBL] [Abstract][Full Text] [Related]
29. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
[TBL] [Abstract][Full Text] [Related]
30. From excess adiposity to insulin resistance: the role of free fatty acids.
Capurso C; Capurso A
Vascul Pharmacol; 2012; 57(2-4):91-7. PubMed ID: 22609131
[TBL] [Abstract][Full Text] [Related]
31. Adipokines: the missing link between insulin resistance and obesity.
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
[TBL] [Abstract][Full Text] [Related]
32. [Cytokines, endothelial dysfunction, and insulin resistance].
de Carvalho MH; Colaço AL; Fortes ZB
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):304-12. PubMed ID: 16767296
[TBL] [Abstract][Full Text] [Related]
33. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance and obesity in childhood.
Chiarelli F; Marcovecchio ML
Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S67-74. PubMed ID: 18805916
[TBL] [Abstract][Full Text] [Related]
35. Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood.
Tan HC; Roberts J; Catov J; Krishnamurthy R; Shypailo R; Bacha F
Pediatr Diabetes; 2015 Sep; 16(6):419-26. PubMed ID: 25800542
[TBL] [Abstract][Full Text] [Related]
36. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots.
Misra A; Vikram NK
Nutrition; 2003 May; 19(5):457-66. PubMed ID: 12714101
[TBL] [Abstract][Full Text] [Related]
37. [Adipose tissue: a multifunctional organ].
Bon GB
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):23S-28S. PubMed ID: 18773748
[TBL] [Abstract][Full Text] [Related]
38. Adipose inflammation, insulin resistance, and cardiovascular disease.
Shah A; Mehta N; Reilly MP
JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
[TBL] [Abstract][Full Text] [Related]
39. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
40. Modulation of cardiovascular function by adipokines.
DeClercq V; Enns JE; Yeganeh A; Taylor CG; Zahradka P
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):59-72. PubMed ID: 22882074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
